Perspective Therapeutics Introduces "Pre-Targeting" Theranostic Technology Platform
Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M ...
Stay updated with breaking news from Transition Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide TargetingReceives up to $2.4M ...
HOUSTON, Jan. 24, 2024 /PRNewswire/ -- Bristow Group Inc. and its subsidiaries announced today that it has entered into a new twelve-year secured equipment financing for an aggregate amount up to...
SEATTLE, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the
SEATTLE, Jan. 17, 2024 -- Perspective Therapeutics, Inc. , today announced that it began patient recruitment for the second dosing cohorts in clinical studies for both of its lead product...
Lantheus will have the option to negotiate an exclusive license to Perspective Therapeutics’ Pb212-VMT-α-NETLantheus will have the option to co-fund and negotiate an exclusive license for certain...